We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$2.27B
AUM Growth
+$198M
(+9.6%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
5.25%
Top 10 Holdings %
Top 10 Hldgs %
35.16%
Holding
449
New
157
Increased
70
Reduced
62
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$84.2M |
| 2 |
Charter Communications
CHTR
|
+$83.5M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$56.6M |
| 4 |
Bank of America
BAC
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$38.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$170M |
| 2 |
T-Mobile US
TMUS
|
+$71.2M |
| 3 |
Advance Auto Parts
AAP
|
+$34.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$27.2M |
| 5 |
VAL
Valspar
VAL
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 15.94% |
| 2 | Healthcare | 14.24% |
| 3 | Communication Services | 13.98% |
| 4 | Consumer Discretionary | 11.95% |
| 5 | Technology | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
226
DELISTED
Clovis Oncology, Inc.
CLVS
| $577K | 0.03% |
+6,141
| New | +$376K |
|
227
ITT
ITT
$17.5B
| $576K | 0.03% |
14,408
-3,597
| -20% | -$143K |
|
228
Aon
AON
$77.3B
| $566K | 0.02% |
+4,258
| New | +$538K |
|
229
Labcorp
LH
$24.3B
| $563K | 0.02% |
+4,259
| New | +$522K |
|
|
TIF
230
DELISTED
Tiffany & Co.
TIF
| $557K | 0.02% |
+5,926
| New | +$544K |
|
|
UFS
231
DELISTED
DOMTAR CORPORATION (New)
UFS
| $556K | 0.02% |
+14,641
| New | +$549K |
|
232
Cable One
CABO
$213M
| $547K | 0.02% |
+769
| New | +$528K |
|
233
Adobe
ADBE
$89.5B
| $544K | 0.02% |
3,856
-35
| -0.9% | -$4.79K |
|
234
Owens Corning
OC
$11.5B
| $535K | 0.02% |
+7,978
| New | +$500K |
|
235
Huntington Ingalls Industries
HII
$11.3B
| $534K | 0.02% |
+2,872
| New | +$562K |
|
|
VMW
236
DELISTED
VMware, Inc
VMW
| $529K | 0.02% |
+6,083
| New | +$561K |
|
237
eBay
EBAY
$48.6B
| $527K | 0.02% |
+15,049
| New | +$515K |
|
238
American Airlines Group
AAL
$9.58B
| $516K | 0.02% |
+10,318
| New | +$480K |
|
|
ATHN
239
DELISTED
Athenahealth, Inc.
ATHN
| $508K | 0.02% |
+3,602
| New | +$450K |
|
|
SGMO
240
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $507K | 0.02% |
+56,314
| New | +$361K |
|
|
LVNTA
241
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $506K | 0.02% |
+9,735
| New | +$509K |
|
242
Yelp
YELP
$1.38B
| $504K | 0.02% |
+16,808
| New | +$524K |
|
|
TWTR
243
DELISTED
Twitter, Inc.
TWTR
| $502K | 0.02% |
+27,885
| New | +$475K |
|
|
KAACU
244
DELISTED
Kayne Anderson Acquisition Corp. Unit
KAACU
| $500K | 0.02% |
500,000
| – | – |
|
245
Align Technology
ALGN
$12B
| $491K | 0.02% |
+3,271
| New | +$444K |
|
246
lululemon athletica
LULU
$13B
| $489K | 0.02% |
+8,149
| New | +$424K |
|
247
Neurocrine Biosciences
NBIX
$17.7B
| $464K | 0.02% |
10,093
-14,535
| -59% | -$705K |
|
248
Criteo
CRTO
$1.03B
| $439K | 0.02% |
8,967
| – | – |
|
|
NVRO
249
DELISTED
NEVRO CORP.
NVRO
| $437K | 0.02% |
+5,906
| New | +$473K |
|
250
Worthington Enterprises
WOR
$2.76B
| $433K | 0.02% |
+14,030
| New | +$376K |
|
Similar funds
Marshall Wace's Q2 2017 Portfolio in Review
As of Q2 2017, Marshall Wace held 449 positions worth $2.27B, up 9.6% from $2.07B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $119M of net new capital in Q2 2017, opening 157 new positions and adding to 70 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Zoetis, an estimated $170M trimmed.
- Marshall Wace's largest Q2 2017 buy was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
- Marshall Wace added most to Reynolds American Inc in Q2 2017, an estimated $84.2M increase.
- Marshall Wace's biggest Q2 2017 reduction was Zoetis, cutting an estimated $170M.
- Marshall Wace fully exited Advance Auto Parts in Q2 2017, selling an estimated $34.1M.
- Marshall Wace's ten largest holdings make up 35% of its $2.27B portfolio in Q2 2017.
- Marshall Wace opened 157 new positions and closed 148 in Q2 2017.
- Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $2.27B.
Based on Marshall Wace's 13F filing for Q2 2017, filed 4 Aug 2017.